Unlimited Potential: The Innovation Renaissance Is Now

GIPC index cover

By Patrick Kilbride At no other time in history has humanity enjoyed such a boundless period of innovation.  The human experience is literally changing day-to-day as new medicines and new technologies create solutions to seemingly insurmountable global challenges such as poverty, hunger, disease, and climate change.  This 21st century innovation renaissance could not be more […]

WHO Still Finding Its Way On Financing R&D For Diseases Affecting Poor Countries

WHO EB 2

In search of sustainable innovation models for cures for diseases affecting primarily developing countries, with the Ebola epidemic as a new reminder of the necessity and urgency of the matter, the World Health Organization had tasked an expert working group with the search for solutions. Last week, the WHO Executive Board took note of the progress made so far.

Anti-Microbial Resistance, Budget, Reform Raise Debate At WHO Executive Board

Public Health - Bacteria

The World Health Organization Executive Board this week has addressed the relationship between the UN agency and its funders and lobbyists, examined the budget for the next biennium, and looked at the issue of the growing resistance of bacteria to antibiotics. Image Credits: Flickr – NIAID

Gavi Receives Record-Breaking Financial Pledges For Vaccines

Immunisation

Gavi, the Vaccine Alliance, boasted success this week as its biennial replenishment conference attracted US$ 7.5 billion in pledges, which is the organisation said is expected to allow 300 million additional children to be vaccinated in poor countries. The vaccine industry pledged support for “strong” immunisation programmes, while public health advocates called for significant price […]

Uganda: International Standard Book Number Helps Authors, Readers Identify Publications

Africa books

The publishing industry in Uganda is a fast-rising sector, gauging by the many emerging publishing houses and self-publishers. With many titles on display, one of the ways authors and readers identify published works is the use of International Standard Book Number (ISBN).

Year Ahead: Big IP Developments Loom For US Law In 2015

2015 balloon

2014 brought major changes to the United States intellectual property system, particularly in the area of patent law. 2015 promises more of the same, as the new Supreme Court ruling in Teva Pharmaceuticals USA v. Sandoz attests. Here’s a discussion of Teva and other key cases and developments to watch this year.

WIPO Re:Search Celebrates 3 Years, Looks To The Future

Wipo logo 2

Several years ago, the World Intellectual Property Organization set up a project aimed at helping bring together those with intellectual property rights and those with ideas for research to develop medical products for people in need. The project, WIPO Re:Search, has gathered numerous partners and is beginning to look ahead to its next phases, including the possible eventuality of drug development, according to the WIPO secretariat.

WHO Report: Access, Affordability Of Medicines Key To Reducing Non-Communicable Diseases

cancer_861_600x450

A new report from the World Health Organization examines the Global action plan for the prevention and control of noncommunicable diseases 2013-2020 (known as the Global NCD Action Plan) and provides some “lessons learnt from implementation.” The report calls for urgent action by governments to stop the “epidemic” of cancer and mostly preventable diseases from sources like tobacco use, salt intake, physical inactivity, and high blood pressure. This includes ensuring treatment is available and affordable, it says.

Key Hepatitis C Patent Rejected In India

Flickr -  DurhamDundee

Today’s rejection by the Patent Office Controller of India of a patent application by Gilead company for a key drug against hepatitis C is being hailed by advocates as a path to dramatically lower costs of treatment for the disease. Hepatitis C has been noteworthy for exorbitantly priced medicines over the past year. A look at the decision shows that a provision in India’s law continues to stop patent applications if they fail to show sufficient novelty and inventive step – and are subject to opposition.

WHO Executive Board To Address Reform, R&D Financing, Ebola, Budget

WHO

The upcoming World Health Organization Executive Board annual January meeting will be 10 days. Included in the list of issues to be addressed are the engagement of the organisation with lobbyists and donors, antimicrobial resistance, and the potential establishment of a pooled fund of voluntary contributions for research and development for diseases primarily affecting developing countries.